Poly Medicure Share price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,97,416 shares, with a market capitalization of ₹101359490. Its Average Traded Price (ATP) is ₹1715.62, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 10 @ ₹1733.00.
Poly Medicure has an upper circuit limit of ₹2079.60 and a lower circuit limit of ₹1386.40. The total value traded stands at ₹33.87 CR, and the delivery percentage for the day is 41.54%.
The stock is currently traded with a market lot size of 1. Poly Medicure also offers a dividend yield of 0.2%.
Poly Medicure share price chart
Poly Medicure Share Key Metrics
Volume
1.97 L
Market Cap
17565.60 CR
LTQ@LTP
10@1733.00
ATP
1715.62
Var Margin
20.89 %
Circuit Range
1386.4-2079.6
Delivery %
41.54 %
Value
33.87 CR
ASM/GSM
No
Market Lot
1
Poly Medicure Resistance and Support
Pivot 1707.47
Resistance
First Resistance
1732.64
Second Resistance
1752.67
Third Resistance
1777.84
Support
First Support
1687.44
Second Support
1662.27
Third Support
1642.24
Poly Medicure Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Poly Medicure Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-07 | Quarterly Results |
| 2026-05-25 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
| 2025-08-08 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results & Others |
| 2024-10-28 | Quarterly Results & ESOP |
| Ex Date | Record Date | |
|---|---|---|
| 2026-08-28 | 2026-08-29 | View More |
Poly Medicure News
Poly Medicure Ltd - 531768 - Intimation On Rescheduling Of Investor/Analyst Meet.
Poly Medicure announced the rescheduling of its virtual one-on-one investor meeting with Wasatch Global. The meeting, initially set for August 20, 2026, will now take place on August 27, 2026. No unpublished price sensitive information will be shared.
Aug 25 2026 22:51:49
Poly Medicure Ltd - 531768 - Analyst Investor Meet Call Transcript
Poly Medicure held its Q1 FY27 earnings call, reporting standalone revenue of Rs.431 crores (+12.3% YoY) and EBITDA margin of 28%. The company detailed its PolyMed 3.0 strategy, aiming to double revenue by FY30 through organic and inorganic expansion into high-tech segments.
Aug 14 2026 21:47:39
Poly Medicure Ltd - 531768 - Record Date/Cut-Off Date For The Dividend Purpose
Poly Medicure announced August 29, 2026, as the record date for its final dividend of ₹3.50 per equity share for FY 2025-26. This dividend is contingent upon approval at the Annual General Meeting on September 05, 2026.
Aug 14 2026 20:07:45
Poly Medicure Ltd - 531768 - Business Responsibility and Sustainability Reporting (BRSR)
Poly Medicure filed its Business Responsibility and Sustainability Report for FY2025-26. The report highlights the commissioning of a new 9.9 MWp solar power plant and progress on various environmental and social targets.
Aug 14 2026 19:25:58
Poly Medicure Ltd - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Poly Medicure announced the availability of the audio recording for its Q1 FY27 earnings conference call. The call took place on August 10, 2026, at 4:00 PM and covered the unaudited standalone and consolidated financial results.
Aug 10 2026 19:04:20
Poly Medicure Ltd - 531768 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Poly Medicure's monitoring agency report indicates delays in QIP fund utilization for capital expenditure projects, primarily due to revised capex plans for its SEZ Jaipur facility. Project completion now expected by FY27-28.
Aug 10 2026 17:28:06
Poly Medicure Ltd - 531768 - Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. 07Th August, 2026
Poly Medicure reported Q1 FY27 cons. revenue of ₹558.78 crore and net profit of ₹85.27 crore, reflecting 1.18% and 31.1% YoY growth, respectively. The company also acquired 100% equity in Medyneo Comercio for ₹34.08 lakh and re-appointed M/s Jai Prakash & Company as cost auditors.
Aug 07 2026 14:57:49
Poly Medicure Ltd - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Poly Medicure will host an earnings call on August 10, 2026, at 4:00 PM to discuss its unaudited Q1 FY27 financial results. Management will provide insights into the company's performance for the quarter ended June 30, 2026.
Aug 05 2026 14:03:37
Poly Medicure Ltd - 531768 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 07Th August, 2026.
Poly Medicure's board will hold a meeting on August 7, 2026, to consider and approve the unaudited financial results for the first quarter ended June 30, 2026. This meeting will set the financial tone for the new fiscal year.
Jul 31 2026 15:38:29
Poly Medicure Management
| Name | Position |
|---|---|
| Devendra Mehta | Chairman |
| Jugal Kishore Baid | Non Independent & Non Executive Director |
Poly Medicure Similar Stocks
Caplin Point Laboratories Ltd.
2517.20
-23.50 (0.92%)
Astrazeneca Pharma India Ltd.
7106.50
-29.50 (0.41%)
Eris Lifesciences Ltd.
1314.80
2.60 (0.20%)
Cohance Lifesciences Ltd.
449.90
-4.10 (0.90%)
Onesource Specialty Pharma Ltd.
1532.20
14.70 (0.97%)
Shilpa Medicare Ltd.
903.80
1.95 (0.22%)
Alembic Pharmaceuticals Ltd.
813.45
-10.55 (1.28%)
Concord Biotech Ltd.
1481.10
-0.80 (0.05%)
Dr. Agarwal's Health Care Ltd.
507.80
11.15 (2.25%)
Poly Medicure FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in POLYMED
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC